Publications by authors named "Wilbur Pan"

Claim this Profile
P
Pembrolizumab plus chemotherapy for first-line treatment of advanced triple-negative breast cancer.
Amin Haiderali, Min Huang, Wilbur Pan, Katherine G Akers, Dylan Maciel

Future Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant pembrolizumab plus chemotherapy/adjuvant pembrolizumab for early-stage triple-negative breast cancer: quality-of-life results from the randomized KEYNOTE-522 study.
Rebecca Dent, Javier Cortés, Lajos Pusztai, Heather McArthur, Sherko Kümmel, Wilbur Pan

J Natl Cancer Inst· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results from the randomized KEYNOTE-355 study of pembrolizumab plus chemotherapy for Asian patients with advanced TNBC.
Seock-Ah Im, Javier Cortes, David W Cescon, Mastura Md Yusof, Hiroji Iwata, Wilbur Pan

NPJ Breast Cancer· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between event-free survival and overall survival in early-stage triple-negative breast cancer.
Min Huang, Peter A Fasching, Amin Haiderali, Weiguang Xue, Wilbur Pan

Future Oncol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant immunotherapy and chemotherapy regimens for the treatment of high-risk, early-stage triple-negative breast cancer: a systematic review and network meta-analysis.
Javier Cortes, Amin Haiderali, Min Huang, Wilbur Pan, Peter Schmid

BMC Cancer· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab plus chemotherapy in Japanese patients with triple-negative breast cancer: Results from KEYNOTE-355.
Masaya Hattori, Norikazu Masuda, Toshimi Takano, Koichiro Tsugawa, Kenichi Inoue, Wilbur Pan

Cancer Med· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness of Neoadjuvant Pembrolizumab Plus Chemotherapy Followed by Adjuvant Single-Agent Pembrolizumab for High-Risk Early-Stage Triple-Negative Breast Cancer in the United States.
Min Huang, Peter A Fasching, Amin Haiderali, Weiguang Xue, Chelsey Yang, Wilbur Pan

Adv Ther· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Q-TWiST analysis of pembrolizumab combined with chemotherapy as first-line treatment of metastatic triple-negative breast cancer that expresses PD-L1.
Min Huang, Joyce O'Shaughnessy, Amin Haiderali, Wilbur Pan, Peter Hu

Eur J Cancer· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of pembrolizumab plus chemotherapy as first-line treatment in PD-L1-positive metastatic triple-negative breast cancer.
Min Huang, Peter Fasching, Amin Haiderali, Wilbur Pan, Emma Gray

Immunotherapy· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer.
Javier Cortes, Hope S Rugo, David W Cescon, Seock-Ah Im, Mastura M Yusof, Wilbur Pan

N Engl J Med· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Required Versus Self-Directed Use of Virtual Patient Cases on Clerkship Performance: A Mixed-Methods Study.
Sarang Kim, Laura R Willett, Wilbur J Pan, Joyce Afran, John A Walker

Acad Med· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Underutilization of proton therapy in the treatment of pediatric central nervous system tumors: an analysis of the National Cancer Database.
Atif J Khan, Benjamin H Kann, Wilbur Pan, Richard Drachtman, Ken Roberts

Acta Oncol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes and patterns of care in a nationwide cohort of pediatric medulloblastoma: Factors affecting proton therapy utilization.
Andrew S Kopecky, Atif J Khan, Wilbur Pan, Richard Drachtman, Rahul R Parikh

Adv Radiat Oncol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Stroke Mimic: Methotrexate-induced Neurotoxicity in the Emergency Department.
Patrick Rogers, Wilbur J Pan, Richard A Drachtman, Christopher Haines

J Emerg Med· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II trial of a multi-agent oral antiangiogenic (metronomic) regimen in children with recurrent or progressive cancer.
Nathan J Robison, Federico Campigotto, Susan N Chi, Peter E Manley, Christopher D Turner, Wilbur J Pan

Pediatr Blood Cancer· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pediatric primary bone lymphoma-diffuse large B-cell lymphoma: morphologic and immunohistochemical characteristics of 10 cases.
X Frank Zhao, Ken H Young, Dale Frank, Ami Goradia, Michael P Glotzbecker, Wilbur Pan

Am J Clin Pathol· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bilateral orbital myeloid sarcoma as initial sign of acute myeloid leukemia: case report and review of the literature.
Jerry A Shields, Gary A Stopyra, Brian P Marr, Carol L Shields, Wilbur Pan

Arch Ophthalmol· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis